Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice
NCT01552174 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 185
Last updated 2015-09-01
Summary
The purpose of this study is to determine the incidence and characteristics of eyelid inflammatory disorders during general ophthalmological consultations and to demonstrate association between palpebral pathologies and ocular surface pathologies.
Conditions
- Palpebral Pathologies
- Ocular Surface Disease
- Meibomian Gland Dysfunction
Sponsors & Collaborators
-
Iris Pharma
collaborator INDUSTRY -
Axial Biotech, Inc
collaborator INDUSTRY -
Laboratoires Thea
lead INDUSTRY
Principal Investigators
-
José Manuel Benitez del Castillo, Professor · USIO, Departamento de Oftalmología, Hospital Clínico San Carlos, 28040 Madrid, Spain
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- Germany
- Spain
Study Locations
More Related Trials
-
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
NCT01189474 ·Status: COMPLETED ·Phase: PHASE4
-
Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
NCT03557203 ·Status: UNKNOWN
-
Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis
NCT02952079 ·Status: COMPLETED ·Phase: NA
-
Intense Pulsed Light in Meibomian Gland Dysfunction
NCT05089591 ·Status: UNKNOWN ·Phase: NA
-
Mechanisms of Light-based Therapies for Dry Eye Disease
NCT06004895 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction
NCT06520007 ·Status: COMPLETED
-
Crosslinked Hyaluronic Acid With Liposomes and Crocin in Dry Eye
NCT03617315 ·Status: COMPLETED ·Phase: NA
-
Ocular Comfort and Inflammation in Lid Hygiene Therapy
NCT02938078 ·Status: TERMINATED ·Phase: NA
-
Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction
NCT04884243 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
NCT02218489 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD
NCT02621593 ·Status: COMPLETED ·Phase: NA
-
Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction
NCT01979887 ·Status: COMPLETED
-
Treating Lid Wiper Epitheliopathy
NCT06671041 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Determine the Effect of Azasite on Corneal Surface Irregularity
NCT01797107 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland Dysfunction
NCT04469998 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
NCT01679015 ·Status: COMPLETED
-
Tea Tree Oil in the Treatment of Chronic Blepharitis
NCT01073150 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction
NCT01633788 ·Status: COMPLETED ·Phase: PHASE2
-
Diadenosine Polyphosphates and Mucin Associated With Ocular Surface Disorders
NCT03731624 ·Status: UNKNOWN
-
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
NCT00349466 ·Status: COMPLETED ·Phase: PHASE2
-
A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation
NCT06235450 ·Status: RECRUITING ·Phase: PHASE1
-
Treatment Regimens in Meibomian Gland Dysfunction
NCT05594745 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation
NCT07245836 ·Status: TERMINATED ·Phase: PHASE4
-
The Effect of Gland Expression on the Regeneration of Meibomian Gland
NCT06163105 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion
NCT07039461 ·Status: TERMINATED ·Phase: NA